Abstract
UNDERSTANDING the mechanisms of long-term potentiation (LTP) should provide insights into the molecular basis of learning and memory in vertebrates. lonotropic glutamate receptors play a central role in LTP; AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate) receptors and NMDA (N-methyl-D-aspar-tate) receptors mediate synaptic responses that are enhanced in LTP and, in addition, NMDA receptors are necessary for the induction of LTP in most pathways1. There is also circumstantial evidence that metabotropic glutamate receptors (mGluRs) may be involved in LTP because the specific mGluR agonist aminocyc-lopentane dicarboxylate can augment tetanus-induced LTP2 and, under certain circumstances, can itself induce a slow-onset potentiation3,4. But the absence of any effective mGluR antagonist has prevented the determination of whether mGluRs are involved in the induction of tetanus-induced LTP. We report here that (RS)-α-methyl-4-carboxyphenylglycine is a specific mGluR antagonist in the hippocampus and have used this compound to examine the nature of the involvement of mGluRs in LTP. We show that synaptic activation of mGluRs is necessary for the induction of both NMDA receptor-dependent and NMDA receptor-independent forms of LTP in the hippocampus.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bliss, T. V. P. & Collingridge, G. L. Narure 361, 31–39 (1993).
McGuinness, N., Anwyl, R. & Rowan, M. Eur. J. Pharmac. 197, 231–232 (1991).
Zheng, F. & Gallagher, J. P. Neuron 9, 163–172 (1992).
Bortolotto, Z. A. & Collingridge, G. L. Neuropharmacology 32, 1–9 (1993).
Reymann, K. G. & Matthies, H. Neurosci. Lett. 98, 166–171 (1989).
Izumi, Y., Clifford, D. B. & Zorumski, C. F. Neurosci. Lett 122, 187–190 (1991).
Behnisch, T., Fjodorow, K. & Reymann, K. G. NeuroReport 2, 386–388 (1991).
Ito, I. & Sugiyama, H. NeuroReport 2, 333–336 (1991).
Stratton, K. R., Worley, P. F. & Baraban, J. M. Eur. J. Pharmac. 186, 357–361 (1990).
Charpak, S. & Gahwiler, B. H. Proc. R. Soc. B243, 221–226 (1991).
Hu, G.-Y. & Storm, J. F. Acta physiol. scand. 145, 187–191 (1992).
Desai, M. A., Smith, T. S. & Conn, J. P. Synapse 12, 206–213 (1992).
Eaton, S. A. et al. Eur. J. Pharmac. 244, 195–197 (1993).
Aramori, I. & Nakanishi, S. Neuron 8, 757–767 (1992).
Irving, A. J., Schofield, G., Watkins, J. C., Sunter, D. C. & Collingridge, G. L. Eur. J. Pharmac. 186, 363–365 (1990).
Stratton, K. R., Worley, P. F. & Baraban, J. M. Eur. J. Pharmac. 173, 235–237 (1989).
Stanton, P. K., Chattarji, S. & Sejnowski, T. J. Neurosci. Lett. 127, 61–66 (1991).
Collingridge, G. L., Kehl, S. J. & McLennan, H. J. Physiol., London. 334, 33–46 (1983).
Harris, E. W. & Cotman, C. W. Neurosci. Lett. 70, 132–137 (1986).
Kauer, J. A., Malenka, R. C. & Nicoll, R. A. Nature 334, 250–252 (1988).
Lovinger, D. M., Wong, K. L., Murakami, K. & Routtenberg, A. Brain Res. 436, 177–183 (1987).
Malinow, R., Madison, D. V. & Tsien, R. W. Science 245, 862–866 (1989).
Reymann, K. G., Frey, U., Jork, R. & Matthies, H. Brain Res. 440, 305–314 (1988).
Sladeczek, F., Pin, J-P., Recasens, M., Bockaert, J. & Weiss, S. Nature 317, 717–719 (1985).
Nicoletti, F. et al. J. Neurochem. 46, 40–46 (1986).
Harvey, J., Frenguelli, B. G., Sunter, D. C., Watkins, J. C. & Collingridge, G. L. Br. J. Pharmac. 104, c79 (1991).
Kelso, S. R., Nelson, T. E. & Leonard, J. P. J. Physiol., Lond 449, 705–718 (1992).
Aniksztejn, L., Otani, S. & Ben-Ari, Y. Eur. J. Neurosci. 4, 500–505 (1992).
Malenka, R. C. Neuron 6, 53–60 (1991).
Dumuis, A., Pin, J. P., Oomagari, K., Sebben, M. & Bockaert, J. Nature 347, 182–184 (1990).
Irving, A. J., Collingridge, G. L. & Schofield, J. G. Cell Calcium 13, 293–301 (1992).
Martin, M. R. Neuropeptides 4, 45–30 (1983).
Bramham, C. R. Neurochem. Int. 20, 441–445 (1992).
Derrick, B. E., Rodriguez, S. B., Lieberman, D. N. & Martinez, J. L. Jr, J. Pharmac. exp. Ther. 263, 725–733 (1992).
Blanton, M. G., LoTurco, J. J. & Kreigstein, A. R. J. neurosci. Meth. 30, 203–210 (1989).
Davies, S. N. & Collingridge, G. L. Proc. R. Soc. B236, 373–384 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bashir, Z., Bortolotto, Z., Davies, C. et al. Induction of LTP in the hippocampus needs synaptic activation of glutamate metabotropic receptors. Nature 363, 347–350 (1993). https://doi.org/10.1038/363347a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/363347a0
This article is cited by
-
Side-by-side comparison of the effects of Gq- and Gi-DREADD-mediated astrocyte modulation on intracellular calcium dynamics and synaptic plasticity in the hippocampal CA1
Molecular Brain (2021)
-
Endogenous formaldehyde is a memory-related molecule in mice and humans
Communications Biology (2019)
-
Separate Gene Transfers into Pre- and Postsynaptic Neocortical Neurons Connected by mGluR5-Containing Synapses
Journal of Molecular Neuroscience (2019)
-
Molecular mechanisms of group I metabotropic glutamate receptor mediated LTP and LTD in basolateral amygdala in vitro
Psychopharmacology (2017)
-
Coordinated activation of distinct Ca2+ sources and metabotropic glutamate receptors encodes Hebbian synaptic plasticity
Nature Communications (2016)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.